Previous Article | Next Article 
Molecular and Cellular Biology, November 2005, p. 9874-9885, Vol. 25, No. 22
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.22.9874-9885.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Smooth Muscle-Specific Genes Are Differentially Sensitive to Inhibition by Elk-1
Jiliang Zhou,
Guoqing Hu, and
B. Paul Herring*
Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202-5120
Received 14 June 2005/
Returned for modification 1 July 2005/
Accepted 8 September 2005
Understanding the mechanism of smooth muscle cell (SMC) differentiation will provide the foundation for elucidating SMC-related diseases, such as atherosclerosis, restenosis, and asthma. In the current study, overexpression of Elk-1 in SMCs down-regulated expression of several endogenous smooth muscle-restricted proteins, including telokin, SM22
, and smooth muscle
-actin. In contrast, down-regulation of endogenous Elk-1 in smooth muscle cells increased the expression of only telokin and SM22
, suggesting that smooth muscle-specific promoters are differentially sensitive to the inhibitory effects of Elk-1. Consistent with this, overexpression of the DNA binding domain of Elk-1, which acts as a dominant-negative protein by displacing endogenous Elk-1, enhanced the expression of telokin and SM22
without affecting expression of smooth muscle
-actin. Elk-1 suppressed the activity of smooth muscle-restricted promoters, including the telokin promoter that does not contain a consensus Elk-1 binding site, through its ability to block myocardin-induced activation of the promoters. Gel mobility shift and chromatin immunoprecipitation assays revealed that Elk-1 binds to a nonconsensus binding site in the telokin promoter and Elk-1 binding is dependent on serum response factor (SRF) binding to a nearby CArG box. Although overexpression of the SRF-binding B-box domain of Elk-1 is sufficient to repress the myocardin activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain. In addition, reporter gene assays demonstrate that an intact Elk-1 binding site in the telokin promoter is required for Elk-1 to maximally inhibit promoter activity. Together, these data suggest that the differential sensitivity of smooth muscle-specific genes to inhibition by Elk-1 may play a role in the complex changes in smooth muscle-specific protein expression that are observed under pathological conditions.
* Corresponding author. Mailing address: Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202-5120. Phone: (317) 278-1785. Fax: (317) 274-3318. E-mail:
pherring{at}iupui.edu.
Molecular and Cellular Biology, November 2005, p. 9874-9885, Vol. 25, No. 22
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.22.9874-9885.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Balamotis, M. A., Pennella, M. A., Stevens, J. L., Wasylyk, B., Belmont, A. S., Berk, A. J.
(2009). Complexity in Transcription Control at the Activation Domain-Mediator Interface. Sci Signal
2: ra20-ra20
[Abstract]
[Full Text]
-
Zhou, W., Negash, S., Liu, J., Raj, J. U.
(2009). Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin. Am. J. Physiol. Lung Cell. Mol. Physiol.
296: L780-L789
[Abstract]
[Full Text]
-
Zhou, J., Blue, E. K., Hu, G., Herring, B. P.
(2008). Thymine DNA Glycosylase Represses Myocardin-induced Smooth Muscle Cell Differentiation by Competing with Serum Response Factor for Myocardin Binding. J. Biol. Chem.
283: 35383-35392
[Abstract]
[Full Text]
-
Passman, J. N., Dong, X. R., Wu, S.-P., Maguire, C. T., Hogan, K. A., Bautch, V. L., Majesky, M. W.
(2008). A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc. Natl. Acad. Sci. USA
105: 9349-9354
[Abstract]
[Full Text]
-
Zhang, H.-M., Li, L., Papadopoulou, N., Hodgson, G., Evans, E., Galbraith, M., Dear, M., Vougier, S., Saxton, J., Shaw, P. E.
(2008). Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1. Nucleic Acids Res
36: 2594-2607
[Abstract]
[Full Text]
-
Freddie, C. T., Ji, Z., Marais, A., Sharrocks, A. D.
(2007). Functional interactions between the Forkhead transcription factor FOXK1 and the MADS-box protein SRF. Nucleic Acids Res
0: gkm528v1-10
[Abstract]
[Full Text]
-
McDonald, O. G., Owens, G. K.
(2007). Programming Smooth Muscle Plasticity With Chromatin Dynamics. Circ. Res.
100: 1428-1441
[Abstract]
[Full Text]
-
Parmacek, M. S.
(2007). Myocardin-Related Transcription Factors: Critical Coactivators Regulating Cardiovascular Development and Adaptation. Circ. Res.
100: 633-644
[Abstract]
[Full Text]
-
Kawai-Kowase, K., Owens, G. K.
(2007). Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol.
292: C59-C69
[Abstract]
[Full Text]
-
Oettgen, P.
(2006). Regulation of Vascular Inflammation and Remodeling by ETS Factors. Circ. Res.
99: 1159-1166
[Abstract]
[Full Text]
-
Herring, B. P., El-Mounayri, O., Gallagher, P. J., Yin, F., Zhou, J.
(2006). Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am. J. Physiol. Cell Physiol.
291: C817-C827
[Abstract]
[Full Text]
-
Pipes, G.C. T., Creemers, E. E., Olson, E. N.
(2006). The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis.. Genes Dev.
20: 1545-1556
[Abstract]
[Full Text]